ArticleProceedings (Baylor University. Medical Center)
Prevalence of obesity and related comorbidities in West Texas: a comparison study before and after COVID.
Article in Proceedings (Baylor University. Medical Center). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Programmable Microbiome: Integrative AI and Multi-Omics Frameworks for Precision T2DM Management.Biology · 2026Review
- Prevalence and paradox: obesity and its comorbid conditions in the modern treatment era.Proceedings (Baylor University. Medical Center)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity remains a major public health issue in the USA, and West Texas lacks updated regional data, especially following the COVID-19 pandemic. This study compared the prevalence of obesity and its comorbidities in adults in West Texas from 2020 to 2022 to a previously published cohort from 2016 to 2018. Methods: A retrospective cross-sectional study used deidentified patient data from Texas Tech University Health Sciences Center Internal Medicine Clinic. Adults aged 18 to 89 with at least two visits between 2020 and 2022 were included. Body mass index (BMI, kg/m Results: Of the 3595 patients included, 51% were obese, 30% were overweight, and 19% had normal BMI. Compared to 2016 to 2018, obesity prevalence increased (51% vs 46.6%). The prevalence of hypertension and obstructive sleep apnea increased across all BMI groups. Diabetes prevalence decreased in the obese group (51.2% to 47%) and remained stable in others. Hyperlipidemia decreased in the obese category (60.3% to 48%) but increased in the normal BMI category. Coronary artery disease prevalence decreased in overweight and obese groups. COVID-19 was significantly more prevalent among overweight and obese patients. Conclusions: Obesity prevalence and several key comorbidities, including hypertension, obstructive sleep apnea, and COVID-19, increased in West Texas during the 2020 to 2022 period. Although diabetes and hyperlipidemia declined among individuals with obesity, the overall burden of obesity remains substantial. These findings highlight the need for continued monitoring and targeted strategies to address chronic disease risk in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.